Garvey LJ, Smith CJ, Stingone C, et al. Fall in HCV incidence in hiv+MSM in London following wider access to DAA therapy. CROI 2019, abstract 85.
Homologe en heterologe COVID-19-boostervaccinaties veilig en immunogeen
mrt 2022 | Vaccinatie, Virale infecties